指南与共识放疗物理与技术姑息放疗与转移瘤

以患者为中心的放射性药物治疗照护路径框架:ASTRO共识文件

A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2020-11-26

该ASTRO共识文件提出一个可广泛适用于所有放射性药物治疗(RPT)的以患者为中心的照护路径框架,旨在推动RPT成为多种癌症的标准治疗。框架强调多学科RPT照护团队在影像采集、解读、剂量学计算、质量保证与安全及肿瘤照护中的协作核心作用。

要点

  • 提出可广泛适用于所有RPT的以患者为中心照护路径框架。
  • 强调多学科RPT团队在影像、剂量学、安全与肿瘤照护中的核心作用。
  • 框架由ASTRO专责小组制定并经公开评论与外部审核。

核心结论

  • 开发以患者为中心的照护路径框架是将RPT确立为多种癌症标准治疗的关键步骤。
  • 不断扩大的RPT治疗选择将影响更大规模的复杂癌症患者群体。
  • 该以患者为中心的照护路径指导具有及时性,应有助于指导未来临床RPT实践范式。

研究设计与样本

  • 专责小组于2019年5月从ASTRO治疗诊断学工作组中招募,核医学界有同等代表。
  • 专责小组扩展了最初由患者中心照护工作组构想的框架,以整合放射肿瘤科医师与核医学医师的优势。

主要发现

  • RPT是预期增长和重要的领域,多种药物已临床使用,新药处于后期临床试验,更多在测试和开发中。
  • RPT治疗选项的增加将要求具备影像采集、影像解读、定量影像、剂量学计算、放射质量保证与安全及肿瘤照护与RPT后遗症和反应评估等专长的合格人员加强协调与合作。

临床怎么用

  • 应建立以患者为中心的RPT照护路径框架,以支持RPT作为标准治疗的应用。
  • 应在多学科肿瘤照护中发挥不断演进的RPT照护团队的核心作用,加强影像、剂量学、质量安全与临床照护的协调合作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiopharmaceutical therapy (RPT) is an area of projected growth and importance with several agents in clinical use, new agents in late-phase clinical trials, and many others under testing and development. This article proposes a framework for developing pathways of care that can be broadly applied to all RPTs, representing the current status of RPT. It suggests foundational elements for many pathways of care for patients with cancer and concludes with areas in active development and the future horizon for RPT treatment centers. Developing a framework for patient-centered pathways of care is a critical step in establishing RPT as standard therapy for patients with a diverse spectrum of cancers. This expected increase in RPT treatment options will affect a much larger population of patients with complex cancer. It will also require enhanced coordination and collaboration among appropriately qualified personnel with diverse expertise in image acquisition, image interpretation, quantitative imaging, dosimetry calculation, radiation quality assurance and safety as well as oncology care and RPT-induced sequelae and response assessment. The essential role of this evolving RPT care team within multidisciplinary oncology care is a cornerstone of this framework for a patient-centered pathway of care for RPT. Given the status of current RPT practice and the horizon for future applications, this patient-centered pathway of care guidance is timely and should help inform future clinical RPT practice paradigms. A task force was recruited from the Theranostic Working Group of the American Society for Radiation Oncology (ASTRO) in May 2019 with equal representation from the nuclear medicine community. The task force expanded on a framework that was originally conceived by the Working Group for patient-centered care. This framework was developed to incorporate the strengths of both radiation oncologists and nuclear medicine physicians. The manuscript was then developed by the task force and posted on the ASTRO website for a 6-week public comment period ending in July 2020. Comments were adjudicated, and the draft was sent to external organizations for potential endorsement. This document was sent to the ASTRO Board of Directors in October 2020 for approval.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Buatti JM, Pryma DA, Kiess AP, et al. A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document. Int J Radiat Oncol Biol Phys. 2020. PMID: 33249143. doi:10.1016/j.ijrobp.2020.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。